Call for Papers
Annals of Biomedical Science and Engineering (ABSE) invites researchers, scientists, and innovators from around the world to submit their latest findings for publication in upcoming issues. We aim to publish high-quality, peer-reviewed research that advances scientific knowledge and technological innovation at the intersection of biomedical science, engineering, and healthcare.
Open Invitation to Authors
We welcome submissions that contribute to new discoveries, technological advances, and translational applications that improve human health. Whether your work focuses on molecular-level biomedical research or engineering innovations for healthcare systems, ABSE provides an international platform for visibility, impact, and collaboration.
All manuscripts undergo a double-blind peer review process and are published under the CC BY 4.0 license, ensuring global accessibility and citation opportunities.
Submission Deadline for the Upcoming Issue:
Manuscripts are accepted on a rolling basis and published upon acceptance. Authors are encouraged to submit early for priority consideration.
Focus Areas
Topics of interest include, but are not limited to:
- Biomedical Engineering, Biomaterials, and Tissue Engineering
- Nanomedicine, Drug Delivery, and Nano-bio Interactions
- Biomechanics, Biomechatronics, and Rehabilitation Engineering
- Bioinformatics, Computational Biology, and Machine Learning in Medicine
- Biomedical Imaging, Instrumentation, and Signal Processing
- Neural Engineering, Brain-Computer Interfaces, and Neuroprosthetics
- Clinical Engineering, Diagnostics, and Point-of-Care Devices
- Telemedicine, eHealth, and AI-based Healthcare Systems
- Public Health Engineering, Biostatistics, and Systems Modeling
- Regenerative Medicine, Stem Cell Engineering, and Gene Therapy
Article Types Accepted
- Original Research Articles: Full-length papers with significant new findings.
- Review Articles: Comprehensive analyses summarizing current trends and knowledge.
- Short Communications: Concise reports on novel results of immediate importance.
- Case Reports and Technical Notes: Descriptions of innovative procedures, devices, or applications.
- Editorials and Perspectives: Thought-provoking discussions on emerging challenges and technologies.
Benefits of Publishing with ABSE
- Open Access Visibility: All papers are freely accessible worldwide.
- Peer Review Integrity: Rigorous double-blind process ensuring quality and fairness.
- Rapid Publication: Accepted manuscripts are published promptly after final acceptance.
- DOI Assignment: Each article is indexed with a CrossRef DOI for permanent accessibility.
- Archiving: Long-term preservation in recognized digital archives such as Portico and SHERPA/RoMEO.
- Author Support: Dedicated editorial assistance and post-publication promotion.
Manuscript Submission Process
- Prepare your manuscript following the Submission Guidelines and Author Guidelines.
- Submit via the online submission system available on the journal website.
- Track progress through the OJS dashboard and communicate with the editorial team as needed.
Authors are encouraged to include ORCID IDs for all contributors and ensure data transparency according to FAIR (Findable, Accessible, Interoperable, Reusable) principles.
Special Issues and Thematic Collections
ABSE regularly announces Special Issues on emerging topics in biomedical engineering and applied sciences. Guest Editors are invited from leading global institutions. Proposals for upcoming thematic issues can be sent to [email protected].
“Your research deserves to reach a global audience. Contribute your next article to ABSE — where science meets engineering for a healthier future.”
Important Dates
- Submission Window: Open throughout the year
- Publication Frequency: Continuous publication (articles published as soon as accepted)
- Average Review Time: 3–4 weeks from submission to first decision
Contact for Queries
For questions related to submissions or suitability of manuscripts, authors may contact:
- Email: [email protected]
- Alternate Email: [email protected]